Protein glycosylation in disease: new insights into the congenital muscular dystrophies
Authors:
- Derek J. BlakeDBDerek J. Blake
- 1 April 2003
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 24 (4) , 178-183
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Recombinant micro-genes and dystrophin viral vectorsNeuromuscular Disorders, 2002
- Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophyNature, 2002
- Post-translational disruption of dystroglycan–ligand interactions in congenital muscular dystrophiesNature, 2002
- Deficiency of α-Dystroglycan in Muscle–Eye–Brain DiseaseBiochemical and Biophysical Research Communications, 2002
- Congenital Disorder of Glycosylation IId (CDG-IId) - A New Entity: Clinical Presentation with Dandy-Walker Malformation and MyopathyNeuropediatrics, 2002
- Three-dimensional structures of the Mn and Mg dTDP complexes of the family GT-2 glycosyltransferase SpsA: a comparison with related NDP-sugar glycosyltransferases 1 1Edited by R. HuberJournal of Molecular Biology, 2001
- Human Brain Malformations and Their Lessons for Neuronal MigrationAnnual Review of Neuroscience, 2001
- Fringe benefits to carbohydratesNature, 2000
- Dystrophin expression in the mdx mouse restored by stem cell transplantationNature, 1999
- Glycoproteins: what are the sugar chains for?Trends in Biochemical Sciences, 1989